Introduction
============

Cancer is the second most common cause of mortality worldwide after cardiovascular diseases, and is responsible for more than 8 million deaths yearly \[[@b1-ophrp-10-177]\]. It represents a burden on almost every country in the world \[[@b2-ophrp-10-177]\]. In spite of recent advances in therapeutic options for many cancer types, the number of newly diagnosed cases is increasing. This is in part due to demographic ageing of the population worldwide, and the evolution of industries and technologies in almost every field, with continuous introduction of new chemicals, techniques and exposures. All of these advances are useful to humanity, yet, have major known and unknown health risks \[[@b3-ophrp-10-177]\]. In 2011, the World Health Organization published a factsheet which documented that more than 60% of all cancer deaths come from middle and low income countries \[[@b4-ophrp-10-177]\]. This is a warning for policy makers to consider cancer risk factors and prevention, a research priority. This would save the vast amount of resources that are spent on cancer management strategies that are not always successful.

Unless genetic makeup predisposes an individual to cancer, environmental and occupational risk factors may be implicated. In fact, the most realistic model to explain cancer evolution is the "gene-environment interaction" \[[@b5-ophrp-10-177]\]. Potentially, preventable cancer could be attributable to occupational and environmental risk factors. Controlling this will have an impact on global cancer morbidity and mortality rates \[[@b6-ophrp-10-177]\].

Careful analysis of the burden of different types of cancer is of great importance for the appropriate allocation of resources to screen, diagnose, treat, and prevent cancer in Egypt. This current study is a preliminary step in the establishment of an epidemiologic data base for cancer cases in Mansoura city and Dakahlia Governorate.

In Egypt, the National Cancer Registry Program is a hospital-based data registry that was established in 2007. Currently, it is the only formal source for cancer statistics in Egypt. It integrates data from multiple Egyptian governorates to provide cancer statistics \[[@b7-ophrp-10-177]\]. Dakahlia is one of the largest Egyptian Governorates but has never been integrated in the National Cancer Registry Program. This research aimed to analyze data obtained from the Oncology Center of Mansoura University (OCMU) which is one of the two oncology centers that serve Dakahlia Governorate. The objective of the current research was to study the most common types of cancer diagnosed, age, gender, and geographic distribution of cases who attended the OCMU during 2016.

Materials and Methods
=====================

The current descriptive record based cross-sectional study was conducted at the OCMU. It is one of the two oncology centers that serve Dakahlia Governorate in Egypt. Electronic records of all cases who attended the OCMU during 2016 were obtained with permission to be used in the study. There were 12,949 records including double and sometimes triple entries for one case. Records with double or triple entries were processed manually so that each patient had only one electronic record. Data was cleaned and prepared for analysis yielding a total of 12,087 records.

Each electronic record had the following variables; identity, age, gender, address, and diagnosis of the patient. The most common cancer statistics were categorized within 16 age groups separated by 5 years beginning as the group 0--4 years and the last 2 age groups 70--74, and 75+ \[[@b7-ophrp-10-177]\]. The current study used 4 categories that were relevant to the selected cancer types in the study. Frequencies of different diagnoses were generated. The range of diagnoses given to patients who attended the OCMU during 2016 was very large (353 diagnoses) and included malignant, benign, non-tumor, and even nonspecific diagnostic classes. For classification purposes, this study assigned these heterogeneous diagnoses into 24 major categories. The most common types of tumor diagnosed at the OCMU during 2016 were selected for further analysis regarding catchment areas of cases (breast cancer, benign thyroid tumors, leukemia, lymphoma, liver cancer, colorectal cancer, bladder cancer, malignant thyroid tumors, finally, lung and pleural tumors). Frequencies of the selected tumor types were related to the population census of different districts of Dakahlia Governorate in 2016 to obtain proportionate rates that were expressed per 100,000 population. A cartographic presentation is made for catchment areas of cases with breast cancer, benign thyroid tumors, and leukemia ([Figures 1](#f1-ophrp-10-177){ref-type="fig"}[](#f2-ophrp-10-177){ref-type="fig"}--[3](#f3-ophrp-10-177){ref-type="fig"}). Maps of Dakahlia Governorate were obtained from the Egyptian General Organization of Physical Planning, a governmental organization responsible for planning of housing and new cities in Egypt \[[@b8-ophrp-10-177]\]. Population censuses of 2016 were obtained from the Central Agency for Public Mobilization and Statistics, the official agency responsible for collection and statistical analysis of census data in Egypt \[[@b9-ophrp-10-177]\]. All statistical analyses in this current study were performed using IBM SPSS V. 23 (IBM Corp., Armonk, NY, USA). All patients' records were confidential and used only for research purposes. The research protocol was approved by the Institutional Review Board of Mansoura Faculty of Medicine (MD/16.12.17).

Results
=======

During 2016, the total number of cases who attended the OCMU was 12,087. A considerable portion of cases were diagnosed as non-tumors. Breast cancer is the most commonly encountered diagnosis among tumor cases, followed by benign thyroid tumors, leukemia, lymphoma, liver, colorectal, bladder, thyroid, and lung tumors ([Figure 4](#f4-ophrp-10-177){ref-type="fig"}).

Age and gender distribution among all diagnoses (both tumor and non-tumor), are shown in [Figure 5](#f5-ophrp-10-177){ref-type="fig"}. Women aged ≥ 35 \< 60 years were the most prevalent, representing more than 1/3 of cases, whilst girls under 15 years represented the smallest category.

Breast related diseases such as fibroadenosis and breast cancer represented the most common diagnostic category encountered among cases in 2016 (32.92%). This was followed by hematological diseases (such as leukemia), reticuloendothelial system related diseases (such as lymphoma) and gastrointestinal tract related diseases ([Table 1](#t1-ophrp-10-177){ref-type="table"}).

Patients who attended the OCMU were not exclusively from Dakahlia Governorate. A considerable percentage of cases were inhabitants of other governorates that came to Dakahlia Governorate to seek medical and surgical management (26.90% of total cases). This is shown in [Table 2](#t2-ophrp-10-177){ref-type="table"}. Percentage was expressed as part of the total number of cases in each selected tumor type. Leukemia cases had the highest percentage where 39.43% of cases came from other governorates. Colorectal and bladder cancer cases occurred in 38.92% and 37.82% of cases came from other governorates, respectively.

Dakahlia Governorate is divided into 19 districts: Meet Ghamr, Mansoura, Elsinbellaween, Belkas, Aga, Sherbin, Talkha, Dekernis, Elmanzala, Nabaroh, Meniet Elnasr, Tamai Elamdeed, Elmataria, Bani Ebeed, Elgamalia, Meet Salseel, Mahalet Damana, Elkordy, Gamasa. Proportionate rates of the selected tumor types in different districts of Dakahlia Governorate have been expressed as per 100,000 population ([Table 3](#t3-ophrp-10-177){ref-type="table"}). Districts were arranged in a descending manner according to the population census from Central Agency for Public Mobilization and Statistics, Egypt Statistics 2016. Meet Ghamr, the most populated district, had less than expected rates. Mansoura district, which had the second largest population, had the highest rate in breast cancer. Gamasa district had the highest rate in benign thyroid tumors. Mahalet Damana had the highest proportionate rate in leukemia. Meet Salseel district had the highest incidence in 3 tumor types: lymphoma, liver, and bladder cancer. Elkordy district had the highest rate of colorectal cancer cases. Elgamalia had the highest rate of malignant thyroid tumors. Tamai Elamdeed had the highest proportionate rate for lung and pleural tumors.

Cartographical presentation of the catchment areas of cases was constructed. The current study chose 3 of the most common tumor types that were encountered among cases in 2016. Proportionate rates are presented on the maps per 100,000 population according to the Central Agency for Public Mobilization and Statistics, Egypt Statistics census 2016 ([Figures 1](#f1-ophrp-10-177){ref-type="fig"}[](#f2-ophrp-10-177){ref-type="fig"}--[3](#f3-ophrp-10-177){ref-type="fig"}). The Dakahlia districts were given numbers from 1 to 19 according to the population census in 2016 (where number 1 was the most populated district).

Age and gender distribution of the most common tumor types encountered during 2016 have been illustrated in [Table 4](#t4-ophrp-10-177){ref-type="table"}. Breast cancer peaked in females aged ≥ 35 \< 60 years. There were no cases in girls less than 15 years, and only 5 % of cases were ≥ 15 \< 35 years. There were 17 cases of male breast cancer, all were 35 years and older. More than 85% of benign thyroid tumors were diagnosed in females. About half of the cases were in the age group ≥ 35 \< 60 years. Males younger than 15 years represented the group with the smallest number of cases. Regarding leukemia, there was a slight male predominance in all age groups. The percentage of leukemia increased gradually with age groups, peaking at the group ≥ 35 \< 60 years before slightly decreasing afterwards. About half of the cases diagnosed with lymphoma were in the age group ≥ 35 \< 60 years, 1/3 of cases were older, and the rest of the cases were younger with slight male predominance in all age groups. Almost all of the cases of liver cancer were 35 years and older. There was only 1 case in the age group ≥ 15 \< 35 years, and there were no cases younger than 15 years. More than half of the cases were 60 and older. There was a big gap between the number of male and female cases, showing male predominance. There was a slight female predominance in colorectal cancer cases in the total number of cases. This was true for all age groups except for the group aged ≥ 15 \< 35 years. About a 1/5 of cases were in this age group. Half of the cases were in the age group ≥ 35 \< 60 years. Cases 60 years and above represented approximately 2/5 of all the colorectal cancer cases. Like liver cancer, no cases under the age of 15 years were diagnosed. More than 80% of cases of bladder cancer were in males. There was only 1 case of male bladder cancer younger than 35 years. Bladder cancer gradually increased after the age of 35 years. One quarter of cases were in the age group ≥ 35 \< 60 years, and the rest were in the 60 years and older group. Regarding malignant thyroid tumors, about 2/3 of cases were females, and this predominance was true for all age groups until 60 years, where the number of male cases increased to be the same as female cases. There was 1 case of a male who was younger than 15 years. More than half of the cases were in the group ≥ 35 \< 60 years. There were no cases of lung or pleural tumors below the age of 15 years. Only few were younger than 35. About half of the cases were in the group ≥ 35 \< 60 years. As observed in colorectal cancer. The other half of the cases were 60 years and older. In all age groups, males predominated. The number of male cases was about double the number of male cases of lung and pleural tumors.

[Figure 6](#f6-ophrp-10-177){ref-type="fig"} shows that, among patients with breast related diseases, fibroadenosis of the breast represented 37% of cases. Breast cancer was diagnosed in 30% of cases. Benign neoplasms of the breast represented 20% of cases. The remaining 13% of cases were assigned other diagnoses such as breast abscess or inflammatory disorders.

Discussion
==========

This current study observed that breast cancer was the most commonly diagnosed cancer in those who attended the OCMU during 2016, followed by leukemia, lymphoma, liver, colorectal, bladder cancers, lung and pleural tumors. A study that was based upon the National Cancer Registry Program reported that the most common cancer type was liver cancer (23.8%), followed by breast cancer (15.4%), then bladder cancer (6.9%) \[[@b7-ophrp-10-177]\]. There was no contradiction between the 2 studies; the current study analyzed data from the OCMU only, and liver cancer cases in the Gastroenterology Surgery Center. The same was true regarding bladder cancer cases in the Urology Center. Both were specialized centers in the Mansoura University Hospitals. A study that integrates data from all the specialized centers in Mansoura University Hospitals may be expected to yield the same results as Ibrahim et al \[[@b7-ophrp-10-177]\].

More than 1/4 of all cases who attended the OCMU during 2016 were inhabitants of other governorates according to the current study. This may be explained by the long course of disease for many cancer types accompanied by many therapeutic options that can be undertaken. The OCMU is a highly reputable oncology center in Egypt with a new Bone Marrow Transplant Unit and hospice care unit that will be available to patients, providing facilities that are not yet offered in all oncology centers in Egypt.

With regards to the proportionate rates of different tumor types in the 19 districts of the Dakahlia Governorate, Mansoura district had the highest rates for breast cancer. This may require further investigations of environmental influences such as endocrine disruptors. Meet Salseel district had the highest proportionate rates in 3 cancer types; lymphoma, liver, and bladder cancers. This may be due to the Meet Salseel district being a largely agricultural community, where a report has shown an association between non Hodgkin lymphoma and pesticide exposure \[[@b10-ophrp-10-177]\]. Schistosomiasis infection is the main risk factor of bladder cancer in Egypt \[[@b11-ophrp-10-177]\]. It is expected to be high in an agricultural district such as Meet Salseel. Regarding liver cancer, the main risk factor in Egypt is Hepatitis C infection \[[@b12-ophrp-10-177]\]. This may require further investigations of risk factors involved in infection.

Rates cannot be considered as prevalence rates for many reasons; in the data registry used to extract these results, old cases were not delineated from the new cases of those who attended the OCMU for the first time. A portion of cancer patients that lived in some Dakahlia districts attended Oncology Centres in other governorates and they were registered in their data systems but not in the OCMU data system, so the frequencies generated in this study cannot be relied upon to express the real prevalence rates. Another reason is that, in Mansoura, the OCMU covers only some types of cancers; liver cancer is managed in the Gastroenterology Surgery Center in Mansoura University Hospitals; bladder cancer is managed in the Urology Center of Mansoura University Hospitals; tumors that require radiotherapy such as brain tumors are managed in the Nuclear Medicine Center of Mansoura University Hospitals. A considerable portion of cases seek treatment in the Egyptian Ministry of Health Hospitals, or in private clinics. In Egypt, both are considered independent of the OCMU. Finally, the OCMU is 1 of 2 oncology centers in Dakahlia Governorate; the other center is in Meet Ghamr district, this explains the low proportionate rates of all tumor types in this district, because of physical accessibility of Meet Ghamr Oncology Center.

The current study observed that about 2/3 of breast cancer cases were in the age group ≥ 35 \< 60 years; and only 1/3 were older. This finding may suggest endogenous hormonal influences in early reproductive years \[[@b13-ophrp-10-177]\]. Genetic susceptibility could have played a role \[[@b14-ophrp-10-177]\], but the records used in the study did not include a genetic profile of the cases. Exposure to endocrine disruptors such as Bisphenol A (BPA) \[[@b15-ophrp-10-177]\], dioxin exposure \[[@b16-ophrp-10-177]\], and Dichloro Diphenyl Trichloroethane (DDT) \[[@b17-ophrp-10-177]\] exposure may explain the age distribution of cases which is considered less than expected. This raises the suspicion in environmental exposures especially endocrine disruptors. Male breast cancer cases represented 1.4% of cases in this study. In 2005, male breast cancer represented 1% of cases \[[@b18-ophrp-10-177]\]. Currently, it may be expected to be higher because of the progressive nature of the disease \[[@b19-ophrp-10-177]\]. The higher proportion observed in this current study may be suggestive of the impact of endocrine disruption because of the possible association between male breast cancer and hormonal influences as targeted in therapy \[[@b20-ophrp-10-177]\]. About half of the male breast cancer cases in the study were in the age group ≥ 35 \< 60 years and the rest were 60 years and older. It has been reported that male breast cancer is a disease of old age, and the median age of diagnosis is 67 years \[[@b21-ophrp-10-177]\]. This provides further support that exposure to endocrine disruptors may be involved in male breast cancer. The current study suggests further investigation of environmental endocrine disruptor exposure for both female and male breast cancer cases is required.

The current study observed a predominance of benign and malignant thyroid tumors in females, similar to findings by Vanderpump et al \[[@b22-ophrp-10-177]\] in 2011. It was observed in 2015 that thyroid cancer was previously a disease of the 4^th^ and 5^th^ decades of life, but recently, it has been increasingly diagnosed in the 2^nd^ and 3^rd^ decades of life \[[@b23-ophrp-10-177]\]. It was also reported that thyroid cancer peaks in the 4^th^ decade of life in females and later in males \[[@b24-ophrp-10-177]\]. The age group ≥ 35 \< 60 years included most of thyroid cancer cases of this current study for both males and females, which was a greater than expected increase in thyroid tumors in males. This may suggest environmental exposure to excess radiation and requires further investigations.

In the Western world, chronic lymphocytic leukemia is the most common type of adult leukemia and in 2012 the median age of diagnosis was reported to be 65 to 70 years \[[@b25-ophrp-10-177]\]. Another study in 2010 reported that only 11% of patients diagnosed with chronic lymphocytic leukemia were younger than 55 years \[[@b26-ophrp-10-177]\]. Regards acute myeloid leukemia, the median age of diagnosis was 65 years \[[@b27-ophrp-10-177]\]. The current study did not differentiate the pathologic types of leukemia, but patients in the age group ≥ 35 \< 60 years represented the highest percentage. This may be suggestive of environmental exposure. Karakosta and Delicha \[[@b28-ophrp-10-177]\] reported that environmental exposure to petroleum products and pesticides may be associated with chronic lymphocytic leukemia. Tsai et al \[[@b29-ophrp-10-177]\] observed that acute myeloid leukemia may be linked to exposure to benzene, ionizing and non-ionizing radiation, and pesticides. Further investigations of environmental exposures may be required. In the current study, there was a predominance of male cases that had acute myeloid leukemia which was similar to findings in a report by Diehl et al \[[@b30-ophrp-10-177]\] in 1999.

Lymphoma was more common in males in this current study, similar to other recent findings in the UK \[[@b31-ophrp-10-177]\] and Roman et al \[[@b32-ophrp-10-177]\]. The median reported age of diagnosis of lymphoma was 72.4 years with a considerable subtype heterogeneity; for example, the median age of diagnosis of acute myeloid leukemia ranged from 20.3 to 73.7 years \[[@b31-ophrp-10-177]\] in the article of Roman et al \[[@b32-ophrp-10-177]\]. In the current study, about half of the cases were in the age group ≥ 35 \< 60 years, but without the subtypes of lymphoma conclusions cannot be made.

Hepatitis C infection is endemic in Egypt \[[@b33-ophrp-10-177]\]. This may be in part due to parenteral antischistosomal therapy in the last century \[[@b34-ophrp-10-177]\]. Hepatitis C is a known risk factor for liver cancer (25% of cases) \[[@b12-ophrp-10-177]\]. The current study observed that liver cancer increased with age; this may be explained by increased duration of chronic Hepatitis C infection. There was a striking predominance of liver cancer cases in males in this current study similar to a report in 2002 \[[@b35-ophrp-10-177]\].

The current study reported a slight predominance of male cases of colorectal cancer. Gao et al \[[@b36-ophrp-10-177]\] observed that males and females contribute equally to colorectal cancer cases, but similar to this current study males tended to have a higher proportion of cancers of the distal colon. The current study observed that about half of the cases were in the age group ≥ 35 \< 60 years, and 40% of cases were older. Sadeghi Gandomani et al \[[@b37-ophrp-10-177]\] reported that colorectal cancer increased significantly during the 4^th^ decade of life. There was no contradiction between the current study and previous research into colorectal cancer.

Schistosomiasis infection is endemic in Egypt \[[@b38-ophrp-10-177]\]. It is a well-documented risk factor of bladder cancer \[[@b11-ophrp-10-177]\]. Successful control strategies were applied in 1980 and schistosomiasis infection as well as the incidence of bladder cancer, gradually decreased \[[@b39-ophrp-10-177]\]. The current study suggests that because of the decline of schistosomiasis infection rates, bladder cancer cases in the age group ≥ 35 \< 60 years were only 1/4 of the cases, while the rest were cases who were older and were infected before control strategies were in place. Further investigations of the pathologic types of bladder cancer may be informative; transitional cell carcinoma may be due to occupational and environmental exposure (solvents \[[@b40-ophrp-10-177]\]), whereas squamous cell carcinoma was mostly due to schistosomiasis infection \[[@b41-ophrp-10-177]\]. The male to female ratio of bladder cancer has been reported to be 2:1 \[[@b42-ophrp-10-177]\]. In the current study the gap between male and female percentages is larger. This may be because males were more exposed to schistosomiasis infection than females in the Egyptian community \[[@b43-ophrp-10-177]\].

In the current study male cases of lung and pleural tumors were double the female cases. Global statistics reported in 2002 suggest that the age standardized ratios of lung cancer in males and females were 35.5 and 12.1, respectively \[[@b44-ophrp-10-177]\]. An American study in 2011 observed that incidences of lung cancer in males and females were 76.2 and 52.4 per 100,000 population respectively \[[@b45-ophrp-10-177]\]. Data used in the current study did not include the smoking history of lung cancer female patients, but in Egyptian society, smoking among females is relatively uncommon \[[@b46-ophrp-10-177]\]. Further investigations of environmental exposures may be required. Factors that can be suspected are cooking in confined areas without smoke extractors \[[@b47-ophrp-10-177]\], and second hand smoke \[[@b48-ophrp-10-177]\]. About half of the cases in the current study were in the age group ≥ 35 \< 60 years and the other half were older. This may be due to the accumulation of the effects of lung carcinogen exposures such as smoking \[[@b49-ophrp-10-177]\], occupational exposures such as asbestos \[[@b50-ophrp-10-177]\], and environmental exposures such as residential radon gas \[[@b51-ophrp-10-177]\].

The current study observed that among breast disease cases, fibroadenosis is the most common (more than 1/3 of cases), followed by breast cancer (1/3 of the cases). One fifth of cases were benign breast tumors. These findings contradict a study that reported benign breast tumors as the most common and accounted for more than 1/3 of the cases recruited, and fibroadenosis which accounted for about 1/3 of cases \[[@b52-ophrp-10-177]\]. Thorough investigation of the environmental and hormonal risk factors relevant in the study population is required.

An important limitation of this study was that not all cancer cases in Dakahlia Governorate were registered in the data system of the OCMU. Some cases were managed in other specialized centers in Mansoura University Hospitals. Other cases seek treatment in Health Insurance Hospitals, or attend oncology centers in other governorates, so prevalence rates cannot be generated. Integration of data from all centers and hospitals that manage cancer cases in the Dakahlia Governorate is required for generalization. The overall conclusion of this current research suggests possible associations between environmental exposure and the cancer types studied. Further confirmation requires a thorough environmental risk assessment.

Conclusion
==========

Breast cancer followed by benign thyroid tumors, then leukemia, were the most frequently diagnosed tumors among cases who attended the OCMU during 2016 in Egypt. Lymphomas, liver, colorectal, bladder, malignant thyroid, and lung cancers were the next most frequent cancers. The Mansoura district of Dakahlia Governorate had the highest proportionate rate of breast cancer. Cases were mostly in the age group ≥ 35 \< 60 years. The Meet Salseel district had 3 of the highest rates of tumor types (lymphoma, liver, and bladder cancers). Environmental risk factors may be causal and need to be further investigated in a systemized comprehensive environmental risk assessment.

Recommendations
===============

1. Modification of data entry system in the OCMU to
---------------------------------------------------

-   Minimize duplicate entries. After reaching the final diagnosis, all the records with provisional diagnoses should be erased.

-   Reformulation of the diagnostic categories to be more specific and relevant. This study recommends assigning diagnoses into fewer major diagnostic categories. It would be preferable to follow 1 of the national cancer registry systems to pave the way for integrating data from multiple national registries and improve the quality of national cancer statistics.

2. Collaboration between Mansoura University medical and surgical centres
-------------------------------------------------------------------------

-   Research that integrates cancer patients' data from all Mansoura University Hospitals and Centres is needed to explore the prevalence of liver and bladder cancers.

-   Multi-Centre studies including all oncology centres in Egypt are needed. This would provide the actual burden of different types of cancer in Egypt that could be used to set priorities for prevention programs.

3. Environmental studies
------------------------

-   More research is needed to explain the high prevalence of breast cancer in some of the Dakahlia districts. This would highlight environmental and occupational risk factors.

-   Research on environmental and occupational risk factors in the Dakahlia governorates for the most common types of tumor is needed, because these cancers are preventable. This can largely be fulfilled via an environmental risk assessment in the geographical areas that raised suspicion. To date, Mansoura, Mahalet Damana, and Meet Salseel districts are strongly recommended to perform a thorough environmental risk assessment to investigate environmental risk factors.
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###### 

Frequencies and percentages of the major diagnostic categories in the year 2016.

  Diagnostic Category                               Frequency   Percentage
  ------------------------------------------------- ----------- ------------
  Breast related diseases                           3,980       32.92
  Hematological system related diseases             1,634       13.57
  Reticuloendothelial system related diseases       1,100       9.05
  Gastrointestinal tract related diseases           1,085       8.95
  Connective tissue diseases                        965         7.98
  Endocrine system related diseases                 814         6.74
  Female reproductive system related diseases       613         5.07
  Liver and gall bladder related diseases           574         4.77
  Renal system related diseases                     257         2.13
  Respiratory system related diseases               204         1.69
  Nonspecific diagnoses                             160         1.32
  Pancreas related diseases                         139         1.15
  Dermatological diseases                           133         1.10
  Salivary glands related diseases                  94          0.78
  Male reproductive system related diseases         81          0.67
  Mouth including tongue and lip related diseases   78          0.65
  Nervous system related diseases                   53          0.44
  Musculoskeletal system related diseases           43          0.36
  Classes that involves more than one system        41          0.34
  Serous membranes related diseases                 18          0.15
  Classes that express symptoms                     9           0.07
  Cardiovascular system related diseases            7           0.06
  Infections and related diseases                   4           0.03
  Rheumatological diseases                          1           0.01
  Total                                             12,087      100

###### 

Frequencies of the most common tumor types according to catchment areas (from Dakahlia governorate or from other governorates).

  Cancer Type                Dakahlia   Others   Total           
  -------------------------- ---------- -------- ------- ------- -------
  Breast cancer              899        74.36    310     25.64   1,209
                                                                 
  Benign thyroid tumors      502        83.95    96      16.05   598
                                                                 
  All types of leukemia      278        60.57    181     39.43   459
                                                                 
  All types of lymphoma      334        76.96    100     23.04   434
                                                                 
  Liver cancer               302        72.60    114     27.40   416
                                                                 
  Colorectal cancer          124        61.08    79      38.92   203
                                                                 
  Bladder cancer             97         62.18    59      37.82   156
                                                                 
  Malignant thyroid tumors   109        74.15    38      25.85   147
                                                                 
  Lung and pleural tumors    100        75.19    33      24.81   133
                                                                 
  Total                      2,745      1,010    3,755           

###### 

Proportionate rates of the selected tumor types in relation to population census in Dakahlia districts in 2016.

  District         Breast cancer   Benign thyroid tumors   leukemia   Lymphoma   Liver cancer   Colorectal cancer   Bladder cancer   Malignant thyroid tumors   Lung and pleural tumors
  ---------------- --------------- ----------------------- ---------- ---------- -------------- ------------------- ---------------- -------------------------- -------------------------
  Meet Ghamr       1.79            0.38                    0.38       0.77       0.51           0.51                0.64             0.26                       1.28
  Mansoura         48.09           30.08                   12.43      14.05      10.27          1.08                3.42             0.18                       4.50
  Elsinbellaween   10.65           3.25                    4.87       3.97       5.78           0.18                0.36             0.36                       1.44
  Belkas           19.16           9.87                    4.36       5.88       6.26           2.09                2.66             1.90                       2.85
  Aga              10.48           5.04                    3.43       4.64       5.04           1.41                2.02             1.81                       1.61
  Sherbin          9.69            4.36                    7.02       5.81       5.81           1.69                2.42             2.18                       1.94
  Talkha           22.42           16.09                   2.37       3.43       3.96           0.53                0.79             1.06                       0.53
  Dekernis         20.08           12.51                   4.36       6.69       3.78           2.91                0.87             3.78                       1.75
  Elmanzala        10.70           6.81                    4.86       6.16       2.92           0.32                2.27             1.30                       1.30
  Nabaroh          16.37           7.01                    5.85       7.40       6.24           1.95                1.56             0.78                       0.78
  Meniet Elnasr    14.70           6.75                    5.17       7.15       7.55           6.75                4.37             3.58                       3.18
  Tamai Elamdeed   14.33           7.45                    9.75       13.19      14.33          6.31                8.03             5.73                       8.60
  Elmataria        8.47            11.73                   4.56       4.56       3.26           6.51                0.65             0.65                       1.30
  Bani Ebeed       24.02           8.81                    4.00       9.61       8.01           1.60                2.40             3.20                       1.60
  Elgamalia        11.07           3.40                    4.26       3.40       3.40           0.85                5.11             28.94                      0.85
  Meet Salseel     8.68            10.13                   13.02      21.70      23.15          7.23                8.68             5.79                       4.34
  Mahalet Damana   14.13           7.07                    24.73      10.60      19.43          14.13               1.77             5.30                       7.07
  Elkordy          12.52           3.13                    6.26       3.13       12.52          93.93               3.13             28.18                      3.13
  Gamasa           40.87           40.87                   0          0          0              0                   0                0                          0

###### 

Age and gender distribution of cases that attended OCMU during the year 2016 (by frequency and percentage), for the most common tumor types.

  Age and gender             \< 15 years   15 to \< 35 years   35 to \< 60 years   ≥ 60 years   Total                                        
  -------------------------- ------------- ------------------- ------------------- ------------ -------- -------- -------- -------- -------- -------
  Breast cancer              0             0                   0                   60           7        796      10       336      17       1,192
                                                                                                                                             
  \(0\)                      \(0\)         \(0\)               \(5\)               (0.6)        (65.8)   (0.8)    (27.8)   (1.4)    (98.6)   
                                                                                                                                             
  0 (0)                      60 (5)        803 (66.4)          346 (28.6)          1,209                                                     
                                                                                                                                             
  Benign thyroid tumors      5             7                   15                  154          58s      294      8        57       86       512
                                                                                                                                             
  (0.8)                      (1.2)         (2.5)               (25.8)              (9.7)        (49.2)   (1.3)    (9.5)    (14.4)   (85.6)   
                                                                                                                                             
  12 (2)                     169 (28.3)    352 (58.9)          65 (10.9)           598                                                       
                                                                                                                                             
  Leukemia                   33            29                  59                  34           101      74       76       53       269      190
                                                                                                                                             
  (7.2)                      (6.3)         (12.9)              (7.4)               \(22\)       (16.1)   (16.6)   (11.5)   (58.6)   (41.4)   
                                                                                                                                             
  62 (13.5)                  93 (20.3)     175 (38.1)          129 (28.1)          459                                                       
                                                                                                                                             
  Lymphoma                   18            3                   38                  31           126      88       68       62       250      184
                                                                                                                                             
  (4.1)                      (0.7)         (8.8)               (7.1)               \(29\)       (20.3)   (15.7)   (14.3)   (57.6)   (42.4)   
                                                                                                                                             
  21 (4.8)                   69 (15.9)     14 (49.3)           2,130 (30)          434                                                       
                                                                                                                                             
  Liver cancers              0             0                   1                   0            169      28       155      63       325      91
                                                                                                                                             
  \(0\)                      \(0\)         (0.2)               \(0\)               (40.6)       (6.7)    (37.3)   (15.1)   (78.1)   (21.9)   
                                                                                                                                             
  0 (0)                      1 (0.2)       7 (47.3)            218 (52.4)          416                                                       
                                                                                                                                             
  Colorectal cancer          0             0                   14                  7            48       51       34       49       96       107
                                                                                                                                             
  \(0\)                      \(0\)         (6.9)               (3.4)               (23.6)       (25.1)   (16.7)   (24.1)   (47.3)   (52.7)   
                                                                                                                                             
  0 (0)                      21 (10.3)     99 (48.8)           83 (40.9)           203                                                       
                                                                                                                                             
  Bladder cancer             1             0                   0                   0            28       11       96       20       125      31
                                                                                                                                             
  (0.6)                      \(0\)         \(0\)               \(0\)               (17.9)       (7.1)    (61.5)   (12.8)   (80.1)   (19.9)   
                                                                                                                                             
  1 (0.6)                    0 (0)         39 (25)             116 (74.4)          156                                                       
                                                                                                                                             
  Malignant thyroid tumors   1             0                   8                   27           21       58       16       16       46       101
                                                                                                                                             
  (0.7)                      \(0\)         (5.4)               (18.4)              (14.3)       (39.5)   (10.9)   (10.9)   (31.3)   (68.7)   
                                                                                                                                             
  1 (0.7)                    35 (23.8)     79 (53.7)           32 (21.8)           147                                                       
                                                                                                                                             
  Lung and pleural tumors    0             0                   4                   1            45       21       40       22       89       44
                                                                                                                                             
  \(0\)                      \(0\)         \(3\)               (0.8)               (33.8)       (15.8)   (30.1)   (16.5)   (66.9)   (33.1)   
                                                                                                                                             
  0 (0)                      5 (3.8)       66 (49.6)           62 (46.6)           133                                                       

M = males; F = females. Numbers without brackets represent frequencies.

Numbers between brackets represent percentages.

Percentage is expressed as of the total number of each tumor type.
